Alcohol Screening Among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
INVEST_pre-publication.pdf | 163.9 kB | Adobe PDF | Download |
Title: | Alcohol Screening Among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program | Authors: | Klimas, Jan; Muench, John; Wiest, Katharina; et al. | Permanent link: | http://hdl.handle.net/10197/6440 | Date: | 25-Feb-2015 | Online since: | 2016-02-26T02:00:11Z | Abstract: | Problem alcohol use is associated with adverse health and economic outcomes, especially among people in opioid agonist treatment. Screening, brief intervention and referral to treatment (SBIRT) are effective in reducing alcohol use; however, issues involved in SBIRT implementation among opioid agonist patients are unknown. To assess identification and treatment of alcohol use disorders, we reviewed clinical records of opioid agonist patients screened for an alcohol use disorder in a primary care clinic (n =208) and in an opioid treatment program (n = 204) over a two year period. In the primary care clinic, 193 (93%) buprenorphine patients completed an annual alcohol screening and six (3%) had elevated AUDIT scores. Among the patients treated in the opioid treatment program, an alcohol abuse or dependence diagnosis was recorded for 54 (27%) methadone patients. Practitioner focus groups were completed in the primary care (n = 4 physicians) and the opioid treatment program (n = 11 counsellors) to assess experience with and attitudes towards screening opioid agonist patients for alcohol use disorders. Focus groups suggested organizational, structural, provider, patient and community variables hindered or fostered alcohol screening. Alcohol screening is feasible among opioid agonist patients. Effective implementation, however, requires physician training and systematic changes in workflow. | Funding Details: | INVEST Fellowship from the National Institute on Drug Abuse Western States Node of the National Drug Abuse Treatment Clinical Trial Network Substance Abuse and Mental Health Services Administration for SBIRT Oregon ELEVATE: Irish Research Council International Career Development Fellowship co-funded by Marie Cure Actions |
Type of material: | Journal Article | Publisher: | Taylor and Francis | Journal: | Journal of Psychoactive Drugs | Volume: | 47 | Issue: | 1 | Start page: | 65 | End page: | 70 | Copyright (published version): | 2015 Taylor & Francis Group, LLC | Keywords: | Agonist treatment; Addiction; Family medicine; Implementation; Opioids; SBIRT | DOI: | 10.1080/02791072.2014.991859 | Language: | en | Status of Item: | Not peer reviewed | This item is made available under a Creative Commons License: | https://creativecommons.org/licenses/by-nc-nd/3.0/ie/ |
Appears in Collections: | Medicine Research Collection |
Show full item record
SCOPUSTM
Citations
50
10
Last Week
1
1
Last month
checked on Sep 12, 2020
Page view(s) 10
1,949
Last Week
5
5
Last month
20
20
checked on Jan 15, 2021
Download(s)
152
checked on Jan 15, 2021
Google ScholarTM
Check
Altmetric
If you are a publisher or author and have copyright concerns for any item, please email research.repository@ucd.ie and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.